Updated Jul 16, 2026
Patlis Alla has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Patlis Alla appears in BrainStorm Cell Therapeutics Inc. SEC filings dated up to May 29, 2026. The provided context does not specify a role, title, or detailed biographical background. BrainStorm Cell Therapeutics is a biotech company focused on stem cell-based therapies for neurodegenerative diseases. No additional verified public biographical information about Patlis Alla is available from the given SEC context.
| Role | See Remarks |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | BCLI | BRAINSTORM CELL THERAPEUTICS INC. | A — Grant or award | 100.0K | $0.00 |
Patlis Alla appears in BrainStorm Cell Therapeutics Inc. SEC filings dated up to May 29, 2026. The provided context does not specify a role, title, or detailed biographical background. BrainStorm Cell Therapeutics is a biotech company focused on stem cell-based therapies for neurodegenerative diseases. No additional verified public biographical information about Patlis Alla is …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Patlis Alla profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.